Skip to main content

Day: September 17, 2024

Correction: Compagnie de l’Odet : Results in line with expectations after significant changes in scope

 First-half 2024 results September 16, 2024  Results in line with expectations after significant changes in scopeChanges in the scope of consolidation and reclassifications to discontinued operations and assets held for sale in accordance with IFRS 5 include:–        Bolloré Logistics, sold on February 29, 2024, reclassified in 2023 as a business held for sale; –        Lagardère, fully consolidated by Vivendi as of December 1, 2023; –        Editis, deconsolidated since June 21, 2023 and sold on November 14, 2023.Revenue: 10,591 million euros, +4% at constant scope and exchange rates. Adjusted operating income (EBITA (1) (2)): 611 million euros, +10% (3), driven by Communications, despite declining results in Oilfield Logistics and Industry.Net income: 3,869 million euros compared to 207 million euros...

Continue reading

FTI Consulting Launches Cybersecurity Practice in Spain with Appointment of Oliver Gower

Appointment Expands Existing Capabilities in the Market to Align with the Firm’s Global Cybersecurity Offerings MADRID, Sept. 17, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the launch of the firm’s Cybersecurity practice in Spain with the appointment of Oliver Gower as a Senior Managing Director. Mr. Gower joins FTI Consulting from Banco Santander, where he was Head of the Global Cyber Emergency Response Team, following earlier roles at the bank as Global Head of Cyber Investigations and Forensics and Global Head of Public-Private Partnerships. Whilst at Banco Santander, he built the first global response capability for cybersecurity, overseeing incident response, complex investigations, forensics, insider threat and cyber intelligence activities worldwide. In his role at FTI Consulting, Mr. Gower...

Continue reading

Treatment.com AI and SPRYT Join Forces to Improve Patient Access to Healthcare Services

SPRYT has developed an AI receptionist called Asa – Medical Office Assistant (MOA) in your pocket Patients communicate with Asa via standard messaging apps such as WhatsApp and SMS/RCS. No app download required 25% of healthcare spending in the USA stems from administrative tasks such as billing and scheduling. This is over $1Trillion/yr Cost of missed appointments in the US alone is $150 Billion/yr Combining with Treatment AI’s Global Library of Medicine will look to create one of the world’s first AI powered patient onboarding and triaging tools at the time of bookingVANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with SPRYT Limited (“SPRYT”). Both innovative...

Continue reading

Svitzer places order to build the world’s first battery electric methanol tug

Battery-methanol tug renderingRendering of Svitzer’s new battery-methanol tugSvitzer has contracted Uzmar shipyard to build a first of its kind battery-methanol tug for delivery in H2 2025. The 6MWh battery-powered tug will be deployed in Gothenburg and provide zero-emission services across a quarter of Svitzer’s operations in the port. Copenhagen, 17 September 2024: Svitzer, a leading global towage provider, has today announced that it has signed a contract with the Turkish shipyard Uzmar to build a world-first battery-methanol tug. The tug will be based on Svitzer’s innovative TRAnsverse tug design and feature a 6MWh battery supported by dual fuel methanol engines for back-up and range extension. The escort duty tug is expected to conduct more than 90% of its operations using its battery-electric powertrain and conduct...

Continue reading

Nokia launches industry’s most modern data center automation platform built for the AI era

Press releaseNokia launches industry’s most modern data center automation platform built for the AI eraNokia Event-Driven Automation platform aims to reduce network disruptions and service downtime by driving human error in network operations to zero. Multivendor solution brings a modern intent-based approach to network automation, building on Kubernetes. Features digital twin capabilities, GenAI assistance, and integration with wide range of IT service management systems, event notification systems, and cloud management platforms. Decreases operational effort up to 40% by simplifying data center life cycle operations.17 Sept 2024Espoo, Finland – Nokia today announces the availability of its AI era, Event-Driven Automation (EDA) platform. Nokia EDA raises the bar on data center network operations with a modern approach that builds...

Continue reading

WTW launches first-to-market document protection platform

Indigo Vault protects electronic documents against insider threats and cyber theft, using end-to-end post quantum encryption LONDON, Sept. 17, 2024 (GLOBE NEWSWIRE) — WTW, (NASDAQ: WTW), a leading global advisory, broking, and solutions company has launched Indigo Vault, a first-to-market document protection platform that provides advanced cybersecurity for sharing and storage of business sensitive files. The platform is a combination of cloud and local document management systems, that provides protection against insider threats, AI system exposure and cyber theft, by ensuring documents and assets such as Word, Excel spreadsheets, PowerPoint presentations, PDFs and Outlook messages are protected and controlled, while providing minimal disruption to the user. Using WTW-patented, end-to-end quantum resistant security, Indigo Vault...

Continue reading

Aspocomp Group Plc: Composition of Shareholders’ Nomination Board

Aspocomp Group Plc, Stock Exchange Release, September 17, 2024, at 10:20 a.m. Finnish time The following members have been appointed to Aspocomp’s Shareholders’ Nomination Board: – Päivi Marttila, appointed by Etola Group and Erkki Etola – Kyösti Kakkonen, appointed by Joensuun Kauppa ja Kone Oy– Mikko Montonen, Aspocomp’s third largest shareholder Aspocomp’s Shareholders’ Nomination Board consists of three members who represent the company’s three largest shareholders. In addition, the Chairman of the company’s Board of Directors shall serve as an expert member of the Nomination Board unless he or she is appointed as an ordinary member of the Board. The three largest shareholders are determined annually based on the ownership information registered with the company’s shareholders’ register on the first business day...

Continue reading

Rovsing A/S releases its Annual Report 2023/24

Annual Report 2023/24 The Board of Directors of Rovsing A/S (Rovsing) has today approved the Annual Report for the financial year 2023/24. HIGHLIGHTS OF THE YEARDuring the financial year 2023/24, the revenue amounted to DKK 39,3 million (DKK 28,3 million in 2022/23), which is an increase of 39 % (DKK 10,9 million) and the highest revenue in recent history of Rovsing A/S.The EBITDA amounts to DKK 2,9 million (DKK 1,0 million in 2022/23) or an increase of DKK 1,9 million.The EBIT for the financial year 2023/24 amounts to DKK 1,0 million (DKK -1,0 million in 2022/23) and the net profit for the year amounts to DKK 0,2 million (DKK -1,7 million in 2022/23), a culmination of the turnaround process for Rovsing A/S, achieving a positive net result for first time in many years.The order backlog at 30 June 2024 stands at a solid DKK 38,8...

Continue reading

Karolinska Developments portfolio company BOOST Pharma announces positive top-line results from a Phase 1/2 study with over 75% reduction of fracture rates in children with rare bone disease

STOCKHOLM, SWEDEN, September 17 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company BOOST Pharma has presented positive top-line results from a clinical Phase 1/2 study with a potential first-in-class treatment of the rare bone disease osteogenesis imperfecta (OI). The results show that the treatment was safe and well tolerated and that fracture rates were reduced by over 75%. BOOST Pharma is developing a first-in-class and potentially groundbreaking cell-based treatment for the congenital disease osteogenesis imperfecta (OI), a condition characterized by fragile bones, constant fractures and deformities of bones. The treatment is based on a novel cell therapy, using human stem cells, with especially high bone-forming capabilities. The treatment is developed to be administered directly upon...

Continue reading

Green Hydrogen Systems announces new CFO

Company announcement 32/2024 Green Hydrogen Systems announces new CFO Kolding, Denmark, 17 September 2024 – Today, Green Hydrogen Systems has appointed Michael Kaalund as Chief Financial Officer (CFO) and member of the company’s Executive Management. Michael Kaalund will assume the position as of 1 November 2024. Michael brings over 20 years of international leadership experience, with a strong background in finance and general management across a wide range of industries.For the past 15 years, Michael has held CFO roles in both multinational corporations and local businesses, where he developed a comprehensive skill set in finance, IT, HR, and legal operations. His expertise in project-based industrial companies, coupled with his experience working with North European equity funds, will be instrumental as Green Hydrogen Systems...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.